Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D&T) Committee Meeting Results for: September 16, 2015

Drugs and Therapeutics (D & T) Committee Meeting Results September 16, 2015
Drug Name	Review Type	Committee Recommendation	Prior Approval Status- Final Determination
Praluent	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Daklinza	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Cosentyx	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Feraheme	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Technivie	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Corlanor	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Triumeq	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Entresto	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Invega Trinza	New Drug Initial Review	Require Prior Approval	Prior Approval Required

Drugs and Therapeutics (D & T) Committee